Where To Invest Now – May 8, 2017

where to invest now newsletter

Where To Invest Now

May 8, 2017

Where To Invest Now

Market Strategies Newsletter

Sample Issue
Where To Invest Now

Where To Invest Newsletter

Balanced Investing Strategies To Make Money In Up Or Down Markets


A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz



Read the May 8, 2017 – Where To Invest Now Newsletter

in .pdf format HERE

Proven Trading Success

Results From Our Recent Trade Alerts:


163% Profits on SPY Calls in 2 Days

20% Profits on AGQ Calls in 15 Days

100% Profits on SPY Calls in 2 Days

8% Loss on SPY Puts in 1 Day

100% Loss On VRX Calls in 30 Days

89% Profits on SPY Calls in 1 Day

15% Loss on SPY Calls in 2 Days

66% Loss on SCO Calls in 7 Days

41% Profits on SPY Puts in 6 Days

125% Profits on OIH Calls in 6 Days

130% Profits on GS Calls in 9 Days

217% Profits on XOM Calls in 9 Days

205% Profits on XOM Calls in 3 Days

105% Profits on XOM Calls in 3 Days

50% Loss on NUGT Calls in 10 Days

50% Loss on SJM Calls in 7 Days

117% Profits on GLD Calls in 3 days

50% Loss on GLD Calls in 20 days

62% Profits on XOM Calls in 20 days

50% Loss on HL Calls in 2 Days

50% Profits on PFE Calls in 2 Days

50% Loss on SPY Puts in 2 Days

50% Loss on TWTR Calls in 8 Days

31% Profits TWTR Calls in 2 Days

316% Profits on MOS Calls in 13 Days

154% Profits on MOS Calls in 11 Days

100% Profits on MOS Calls in 8 Days


See all trades in past newsletter issues.


These are all of our most recent trades. This presents are Trade Alerts abilities
to limit losses, KEEP GAINS and MAXIMIZE PROFITS to deliver strong returns to our trade alert members.

Join Today to Start Getting Profits Like These.

When you become a Trade Alerts Member:

We Do The Research and Analysis Work,
We Send You The Buy Trades,
You Make The Trades,
We Let You Know When We Are Selling,
You Take and Keep Your Gains.

To get trade alerts WHEN WE MAKE THEM, become a Member today. Go To:


To get the lowest full membership rates available now.


Where To Invest newsletter

Follow Our Marketed Weathered, Time Tested Trading Rules That

Now you can profit from where to invest trade alerts from our traders with over 75 combined years of successful investing experience.


  • Make Money In Up Or Down Markets — Our trading alerts balanced investing strategies are designed and proven to make money in up or down markets.


  • Done For You — All the where to invest research and trading analysis is done for subscribers. This is not a ‘class’ or a ‘training course’. This is us doing ALL the work — from research to sending you text messages on where to invest and what to trade, along with recommended amounts.


  • SAFETY — We strictly follow our Time Tested, Market Weathered Trading Rules that are proven time and time again to protect our (and now your) investment capital from losses while effectively allowing us to Keep The Profits We Make. So even though we trade options to get the profits you see above — We can do it with minimal risk and Maximum Profit Potential.


You Don’t Even Need To Learn Any Trading Skills Or  Anlaysis

+++ We DO IT ALL FOR YOU! +++

We tell you where, when and what to invest in when we make the trades in our accounts, and you get to sit back and enjoy the rewards!
The specific buy and sell trading alerts are sent directly to you by e-mail and text message. So you can get in on and cash out on our winning
trades fast and at the right time.

Get Started with Any Amount – Follow our recommended trading guidelines for a $10,000 portfolio or invest more or invest less — Whatever you are comfortable with. Your investment is protected because Time Tested Trading Rules



Join Us Today. Lock in the Lowest Membership Rates Available HERE



Your Membership includes access to both:


Trade Alerts by Text Message
The Market Investing Strategies
Where To Invest Newsletter
Full Members Edition

Our Where To Invest Now For Profits In Up or Down Markets Newsletter is more compact, informative, effective
and quicker to read then the major, big name publications — AND there are NO ADS to wade through.

The Members Edition Newsletter is sent to you by e-mail Monday Mornings and available in the Members Area along with our archive of past issues.

Text Message Investing Alerts

This Princeton Research, Inc. publication features:


  • Investment Alerts Trade Analysis and Discussion

Head Trader, Charles Moskowitz, reviews trades made, what he is watching now, analysis of where he sees things going and where to investing now in the coming week.

  • Investing Trade Alerts Trade Table, Positions and Performance Summaries

See where we are invested and our performance for the week. This includes trading tables and positions showing profits and losses for the week.

  • Market Indicators Laboratory With Weekly Changes

The Market Laboratory table provides a fast overview guide, giving our readers a great analysis of market sentiment and the general prevailing attitude of investors. This continues to be a strong, solid indicator of where to invest now.


  • Market Strategies Technical Information

This great where to invest now market analysis tool allows you to quickly see, at a glance, support and resistance levels for the major indexes;

Dow, S&P 500, QQQ, Transports and NASDAQ

  • Our Stock and Options Trading Accounts Trade Tables, Positions and Performance Summaries

See where we are invested and our performance for the week. This includes trading tables and positions showing profits and losses for the week. We cover both a $10,000 trading portfolio and a $100,000 trading portfolio. These benchmark levels provide a guideline, enabling our members to scale their investment level amounts up or down depending on the capital they have and are comfortable investing.

  • Undervalued Small Cap Stocks

See coverage of the undervalued, small cap, lower priced stocks we follow. These companies have innovative, life enhancing technologies. They possess the potential to produce significant price upward swings, giving investors big profit returns.

  • Fundamental Analysis Stocks To Buy with Stops

We use fundamental analysis we select top stocks to buy now. Buying these stocks while using stops to protect capital, continues to produce solid, strong profits for us.

  • This Weeks’ Economic Numbers, Earnings Releases and Media Data

See this week’s coming earnings report and economics information. This information provides a tremendous advantage in pin pointing stocks that can perform or drop due to earnings reports. The economic data keeps us up to date on the most important daily where to invest now information coming out.

  • Market Strategies Fundamentals

Fundamental analysis of industries, top stocks, the economy and the markets together with US and World events provides great insight into where the next investment winners will be.

  • Market Strategies Economic Data

Our in-depth analysis of current economic data projects where the economy and the market is going showing us which sectors and companies in them are the strongest investments now.


  • Market Cycles

Our in-depth analysis of market cycles, which are known among top traders as “The Key To Maximum Returns”.


  • Trader’s Almanac

This daily Calendar of Market and Economic Events quickly shows, at a glance, important economic, market and trading events for the month.


Join Us Today.

Lock in the Lowest Membership Rates Available HERE

Gain access to BOTH Services:

Investing Trade Alerts
and The In-depth Market Strategies Where To Invest Newsletter


A Sample of the Where To Invest Now Newsletter Information Our Members Get Follows

Investing Trade Alerts

Charles Moskowitz Discussion

This market has new closing highs in both the S&P500 and the NASDAQ while the DJIA is only 9 points or so off its high close.  The outlier is again the DJ Transports, but it too is in striking distance with only a day or two of solid performance.

The problem for me is the extreme divergences in what the “other” markets are telling us; oil is lower on lack of enough demand vs. supply, commodities such as copper, iron ore, rebar and other building materials are all lower, the Baltic Dry index (shipping) has been going nowhere but down of late, and the yield curve has flattened.  While we have the lowest unemployment is recent history, the wages component shows no real pressure to the upside and while the published rate of 4.4% looks pretty good, the U6 number (including participation rate) is still 8.9%.  Add to this a GDP growth of less than 1% for Q1 and you really have to wonder what to believe.

A very sharp friend of ours sent along an article this week talking about the VIX and its lack of help as an indicator of late.  It’s interesting from the standpoint of what it opines has happened to the VIX trade and how it has “delegitimized” this measurement.

When this happens, and it always does, the last ones in are hurt the worst.  But beyond that, this time it seems to me to be even worse, since the market has moved higher and for longer.  In 1987 the issue was selling naked puts and it was only in vogue for a year or two during which the market “only” moved 150% from its breakout in 1982.  This time we’ve moved 300% since the lows of 2009 in the most complacent period in the history of the stock market.  It has been so ingrained as a “buy the dips” mindset that I shudder to think what could happen if we encounter a real problem.

Most individual investors consider that the best way for them to maintain a diversified portfolio of stocks is to buy and index fund like the SPY (S&P500 ETF) and call it a day.  On the face of it, this makes all the sense in the world, right up until the whole world of traders and other “fund of funds” decide that if the lowest cost and easiest way for them to do no worse than to match the index by which they are judged is to own nothing but that index.  This creates another very crowded trade that may (or may not) perform for you as a solid tool for diversification if the “trade” is using it as a single index.  If you don’t own the SPY, you should still have some SPY puts.  The only reason I did not add any this past week was because we had such wishy-washy days that I never got the chance, but I still favor some short-dated just out of the money puts and any new commitments will be texted this week…CAM


Investing Trade Alerts Summary

$10,000 Trading Account Trade Table


Bought 6 AKAM June $ 55 Calls
Sold 6 GLD May $121 Calls ( 50% Loss Rule )
      366 Loss
Bought 2 SJM June $ 170 Calls
Bought 2 SJM June $ 130 Calls
Bought 6 GLD May $121 Calls
Bought 10 HL June 6th $ 6 Calls


3rd Week expiration when the month is listed without a date


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


Remember, these trades are based on your participation in the

Subscriber Members Only




NOTE: In texting we have a limited amount of words. In the interest of brevity:


The Quantity and Strike Price for each trade is specific. 1=January, 2=February


Trading is hypothetical. We may trade weekly options and they are noted: SPY 1/25 147 for

SPY Jan 25th 147 Calls or Puts.


New Trades Will Be TEXTED To MEMBERS



                   Fundamental Analysis Stocks To Buy with Stops


Using fundamentals the following are stocks to trade hypothetically. They have done well. We have taken numerous profits as indicated on the table below. In addition many have been stopped out with small losses.  All indicated on the table below, balance is critical.


Alibaba has  made a few points. We are raising the stop loss price.


We have no position in Alcoa AA.


Flushing Financial FFIC fell below the 50 day price moving average on March 3rd, which was a selling opportunity. We would take profits in the Flushing Financial.


Boeing is on its way to $ 200.


We are disappointed with Bristol Myers. We originally bought BMY at  $ 49.20 back on October 17th, sold on stop at 55.45 December 7th.


Sell if you are long Hecla Mining, which had been previously stopped out profitably at $ 5.64 on Dec 15th.


We took profits on ENZ but still want to buy at lower prices.


The HDGE is not relevant at this time.


Symbol Name Business Description PE P/S MV mln Price Buy or Sell Limit Stop Loss

Or offset

BABA Alibaba China Similar to Amazon 50.67 13.21 275.5B 116.04 Bought @ $ 111 on 4/7/17 opening 112x
AMZN Amazon Catalog & Mail Order 189 2.90 394B 934.15 Long Sell on stop 869x
SIMO Silicon Motion Semiconductor solutions for mobile storage and communications 9.7 2.5 1.39B  50.34 39.10


CIO City Office


Real Estate Investment Trust high quality Offices 292 5.8 396Mln  12.36 Re Buy at 12.12 11.50x
TPC Tutor Perini Construction 12 0.25 1.3B  28.55

Stopped out28.90




28.90x new stop loss
SAVE Spirit Airlines Discount Airline 13 1.6 3.6B  59.19  48.10 51.00 stopped out 3/17/17
BMY Bristol Myers Biopharmaceutical Products 28 5.1 94.9B  55.15


Sold  at 52.80x


Bought 56.20


BA Boeing Aerospace, commercial jetliners, military systems 14 0.85 81B 185.01  Long at

   132 10/04/16     

New stop loss at $ 174
HL Hecla Mining Basic Materials 44 3.61 1.7B    5.30

Look for re-entry

  Long at     5.24 3/3/17

Sold at $4.84

4.85x Needs to stay above $ 5 to be long
FFIC Flushing Financial Bank Holding company Savings and loans 13 3,5 592Mln  30.25  19.10


Selling opportunity
AA Alcoa Aluminum Processing and Technology N/A 0.4 9.5B  31.82

No position

21.15 originally bought 2/8/16 Sold at 37.89 Re-Bought at 34.40 3/10/17
ENZ Enzo Biochem Life Sciences NA 1.35 134M   8.83 Bought

 at   5.13


Sold on Opening Monday 4/3/17

Sold 8.43

BAC Bank of America Commercial Bank 10 2.02 165.3B  23.74


Bought  at 15.42


23.60x stopped out on 3/21/17
HDGE Advisor Shares Ranger Bear ETF   8.74


 Stopped out at  9.01

2/10 /17

Must close above 8.95 to be long :



MARKET Laboratory – Weekly Changes


Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.



21,006.94            +66.43






S&P 500








Russell 2000








Gold (spot)




  Silver July








Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100         85/100’s


Put/Call Ratios

CBOE Equity





151-26  -1-06

2.97% +0-4%

10 Yr. Note

125-07 -16  2.30%+0.03%






CRB Inflation





Barron’s* Confidence







5 Yr. Note









DJ Utilities

























M1 Money




April 24th




M2 Money




April 24th







* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.



Market Strategies Technical Information



                                                                   SUPPORT                   RESISTANCE

S&P 500                    23.85                                     2420

NASDAQ (QQQ )  137.00                                        139.50

Trans                            90.65                                     92.80

DOW                      20,847                                         21,120

TLT                         120.50                             123.50


$100,000 Trading Portfolio Stock Positions and Trades


Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.





Purchase Price Purchase Date Stop/Loss Price/Date Sold   Profit/


YANG  500   11.97       05/01
LABU   150   46.70       04/24 53.55 5/02 $ 1027
AGQ     150   40.39       04/07
SCO      200   35.05       04/05 39.10  4/25 $   810
VRX      200   11.08       03/16
VRX      400   12.12       03/13
NUGT   300     8.92       03/13
RWM    100 50.60       11/21
SPXU   200 22.88       11/14
CTL       150   23.29       11/04 25.37 5/03 $  312
AMBA   100   63.75       10/13
MOS     200 27.53       05/02
EYES    500 5.04       04/04
EYES  1000 6.49       12/28
TWTR   200 28.51       10/28
MOS     100 43.55       08/14
HL         500 3.95       05/03
SAN      600 8.40       12/16
TEXQY 200 6.56         7/11
REPR* 5000 0.22 10/22/12


Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.



Market Strategies $100,000 Trading Account


There was one options trade;


the purchase and sale of 12 GLD May 121 Calls at $ 1.21, and sold on the 50% Loss Rule at $ 0.60 for a debit of $ 732.


The net in options trading was that loss of the $ 732.


The stock trading made a gain of $ 1339.


The CTL also provided a dividend of $ 243 that we have not included in the results.


For the entire last two years on closed out trades, our hypothetical profits increased by $ 607 to $44,242.


Open trade losses decreased by $ 1,360 from $15,336 to $13,976.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 17 positions: AGQ, AMBA,  EYES( 2 ), HL, MOS  ( 2 ), NUGT, REPR, RWM, SAN, SPXU,TEXQY, TWTR,  VRX (2) and the YANG


The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.


Money management is based on a hypothetical $ 100,000.

The 17 stock positions would cost $ 71,620.

The four long options positions, the 10 HL June 6 Calls and the 4 SJM June 130 Calls

and the 6 AKAM June 55 Calls would require $ 1,320

when combined with the stock requirement of $ 71,620

equals $72,940

which leaves excess cash of $ 27,060.


These figures are approximate and there might be errors.


The trading is hypothetical and we do not count commission costs.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.



Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price


Option Cost Date Sold Date Profit/


AKAM June 55

12 lots



SJM June 130 Calls

8 lots




GLD May 121

12 lots



04/25/17 $ 0.60

( 50% Loss Rule )

05/02/2017 ( $ 732 )
HL June 6

20 lots





Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.



This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY AES AES ( 0.20 vs 0.13 ) JD.Com ( 0.13 vs -0.15 )  Alon ALJ -0.12 vs -0.42 First Data FDC

( 0.28 vs 0.24 ) Hecla HL 0.03 vs 0.02 Newell Brands NWL 0.28 vs 0.40  Platform Specialty

( PAH ( 0.14 vs 0.11 ) Sysco SYY ( .52 vs 0.46 ) Tyson Foods TSN ( 1.02 vs 1.07 )




CB&I CBI ( 0.93 vs 1.01 ) CST Brands CST 0.25 vs 0.24 EOG ( 0.15 vs -0.83 ) Hertz Global

HTZ -0.84 s -0.12 ) Marriott MAR 0.91 vs 0.87 Plains PAA 0.35 Tesoro TSO ( 0.31 vs 1.19 )

TUESDAY Aramark ARMK ( 0.43 vs 0.39 ) Global Partners GLP ( -.05 vs -0.21 ) Henry Schein HSIC

( 1.65 vs 1.41 ) Jacobs JRC 0.71 vs 0.75 Office Depot ODP ( 0.12 vs 0.10 ) U S Foods USFD ( 0.18  ) Sempra Energy SRE ( 1.66 vs 1.27 ) Valeant VRX ( 0.91 vs 1.27 )  


10:00 hrs JOLTS-Job Openings March ( NA vs 5.743Mln )

10:00 hrs Wholesale Inventories March ( -0.1% vs +0.4% )

Amdocs DOX ( 0.93 vs 0.92 ) Atento ATTO ( 0.09 vs 0.13 ) Blue Buffalo BUFF 0.22 vs 0.19

Electronic Arts EA ( 0.75 vs 0.50 ) NVIDIA NVDA ( 0.80 vs 0.46 ) Priceline PCLN ( 8.80 vs

10.54 ) ScanSource SCSC ( 0.67 vs 0.64 ) Walt Disney DIS ( 1.41 vs 1.36 ) YELP .16 v .08

WEDNESDAY Broadridge Fin BR ( 0.62 vs 0.58 ) Conduent CNDT 0.16 COTY ( 0.12 vs 0.09 ) Crocs Inc

CROX ( 0.04 vs 0.07 ) Mylan MYL ( 0.93 vs 0.76 ) Toyota Motor TM ( 119.46 vs 38.38 )

07:00 hrs MBA Mortgage Applications Index 05/05 ( NA vs -0.1% )

08:30 hrs Import Prices April ( NA vs -0.2% )

08:00 hrs Import Price ex-oil April ( NA vs 0.2% )

10:30 hrs Crude Inventories 05/05 ( NA vs -0.93 Mln Bbls )

14:00 hrs Treasury Budget May ( NA vs $106.5Bln )


China Lodging HTHT ( 1.38 vs 1.22 ) Enbridge EEP ( 0.07 vs 0.17 ) Hologic HOLX ( 0.46 vs 0.47  ) Netease.com  NTES ( 3.99 vs 3.12 ) Symantec SYMC 0.28 Whole Fds WFM .37 v.44

THURSDAY Enbridge ENB ( 0.66 vs 0.76 ) Kelly Services KELYA 0.21 vs 0.29 Kohls KSS 0.29 vs 0.31

Macy’s M 0.36 vs 0.40 Orbital ATK OA ( 1.37 vs 1.31 ) Teva Pharma TEVA ( 1.04 vs 1.20 )

08:30 hrs PPI April ( 0.2% vs -0.1% )

08:30 hrs CORE PPI April ( 0.2% vs 0.0% )

08:30 hrs Initial Claims 05/06 ( 242K vs 238K )

08:30 hrs Continuing Claims 04/30 ( NA vs 1964K )

10:30 hrs Natural Gas Inventories 05/06 ( NA vs 67 bcf )

CA Tech CA ( 0.49 vs 0.60 ) Darling Ingredients DAR ( 0.08 vs 0.01 ) Middleby MIDD ( 1.12 vs 0.96 ) Nordstrom JWN ( 0.27 vs 0.36 ) Weibo WB ( 0.21 vs 0.07 )

FRIDAY ArcelorMittal MT ( 0.27 vs -0.23 )JC Penney-0.23 Amaya AYA ( 0.69 vs 0.43 )


08:30 hrs CPI April ( +0.2% vs -0.3% )

08:30 hrs CORE CPI April ( 0.2% vs -0.3% )

08:30 hrs Retail Sales April ( 0.6% vs -0.3% )

08:30 hrs Retail Sales – ex auto April ( 0.5% vs 0.2% )

10:00 hrs Business Inventories March ( 0.1% vs 0.3% )

10:00 hrs Michigan Sentiment – Prelim May ( 96.5 vs 97.0 )



The U.S. Oil Rig Count increased by 6 Rigs to 703. One year ago there were 354 rigs in use. The Nat Gas Rig count increased to a total of 171 and there is two rigs listed as miscellaneous totaling a US rig count of 876. Crude closed lower for a second week at      $46.22, down $3.13   Natural Gas closed the week off $  0.01 or -0.3%,  At $ 3.226



You Don’t Need To Learn Any Trading Skills Or

Do Any Time Consuming Analysis and Tracking


+++ We DO IT ALL FOR YOU! +++


We tell you where, when and how much to trade and you get to sit back and enjoy the rewards!


The specific buy and sell trading alerts are sent directly to you by e-mail and text message. So you can get in on and cash out on our winning trades fast and at the right time.


Get Started with Any Amount – Follow our recommended trading guidelines for a $10,000 portfolio or invest more or invest less — Whatever you are comfortable with. Your investment is protected because Time Tested Trading Rules PROTECT YOUR CAPITAL And KEEP YOUR PROFITS.


Join Us Today.

Lock in the Lowest Membership Rates Available HERE



Undervalued Small Cap Stocks


Lower Priced stocks that look to be a buy:


Repro-Med Systems, Inc. (OTCQX: REPR  0.44 )*   


CHESTER, NY / March 25, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) is pleased to announce that the umbrella organization of the public health insurance in Germany approved the FREEDOM60® Infusion System for reimbursement. The FREEDOM60® System was registered January, 31st 2017 and listed in the Medical Device Registry in the category mechanical infusion pumps.  It is the ONLY device of its kind registered within Germany.


In partnership with ContraCare GmbH, a leader in Germany for Contract Management (reimbursement services) and managed Care, the RMS FREEDOM60®, FreedomEdge®, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™ are now poised to dominate this growing market in Europe.


Torsten Kühn, Chief Executive Officer of ContraCare, commented “as a premium service provider in Germany’s health care system, we aim to partner with leading suppliers to provide the best drugs, medical devices and services to our patients while keeping an eye on the cost efficiency of the treatments we provide. The RMS FREEDOM60® system with its durable and reliable syringe driver and high-quality HIgH-Flo™ subcutaneous safety needle sets are exactly the products we needed for immunoglobulin, antibiotic and many other therapies we are providing today. We are glad that the umbrella organization of Germany’s public health insurance confirms the unmet need by approving the RMS FREEDOM60® System for reimbursement.”


Eric Bauer, Chief Operating Officer of RMS commented, “It can take 12 to 14 months to obtain country registration; by partnering with a leading health care provider, that time was cut significantly.  Contra Care is an exceptional partner and we could not be more pleased with our relationship. Germany is going to be a great market for our high quality products and our ever expanding product line.  RMS continues to be the Global industry leader and create exceptional partnerships around the world to improve patient quality of life.”

RMS Medical Products is the leading manufacturer of medical products used for home infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60® and our latest Freedom Edge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers. The Company’s website may be visited at www.rmsmedicalproducts.com.

Contra Care GmbH, based in Nuremberg, Germany, is specialized in providing Contract Management (reimbursement) Services and managed Care (homecare) solutions for patients with chronic diseases. The company is certificated in accordance with ISO 9001, ISO 27001, ISO 13485 and licensed as a homecare provider of medical devices and treatment services according to German Social Law (SGB).


RMS Medical Products is the leading manufacturer of medical products used for home infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60® and our latest FreedomEdge® Syringe Infusion Pumps, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo™ Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers. The Company’s website may be visited at http://www.rmsmedicalproducts.com.


Enzo Biochem ( ENZ: $ 8.80 )


Enzo Biochem closed the calendar year 2016 at $6.94 a share. For the year it was up 54.22% versus the Dow Jones +13%. The relative strength index was 53.41 which is neutral and short interest declined to 827,800 shares. However the RSI has climbed to over 80 and is now 69.08 on April 1st, 2017. Enzo’s balance sheet closed their first quarter October 31 with $67 million in cash and current equivalents and complete elimination of debt. Both the Clinical Lab and Life Science divisions ended the year profitably. New products were added to their catalog and litigations have moved ahead leaving them as a plaintiff with 6 lawsuits in the Delaware Court and one in the Manhattan Court.


What do I look for in 2017? The market will be interesting in the first half with the Government transition to a new administration. Abbots Summary Judgement request was denied by the Court but the trial date has yet to be set. At some point the 2nd Court of Appeals will rule on Enzo’s appeal on the CT. Courts reversal of the Jury’s decision in the Enzo vs. Apalera Case. The market is giving no value, win or lose, to this decision. The stake is $65 million with no adverse effect if ruled against Enzo. Enzo should again outperform the Dow and S&P in 2017.

Updates on Delaware Litigations

The last earnings report showed a cash position in excess of $65 million with no debt to speak of and a positive cash flow from their operating divisions. The only cash burn is coming from Litigation expenses and a bit from Research and Development. Litigation in Delaware is on a contingency basis as such Enzo is not on the hook for billable hours. To my knowledge there are 6 suits left after 6 have settled.

When the company gets a 500 million dollar market cap ($10.63) they will qualify for those Institutions that can’t buy microcap stocks. A significant number of Institutions will look to be buyers and with only 47 million shares issued and Institutions already owning 50% and insiders owning 15% that leaves less than 17 million shares in the float.


Pressure Bio Sciences OTCQB: PBIO ( 0.28 )*


Recently announced the signing of a new CFO Mr. Joseph L. Damasio Jr. Mr. Damasio has over 20 years of finance and accounting experience most recently as Finance Director at Nelipak Packaging, a private equity backed medical packaging manufacturer with over $ 100 million in global annual sales. Before joining Nelipak, Mr. Damasio held financial positions at CP Bourg,IQEKC, and Kopin Corporation. Mr Damasio was employed by Pressure BioSciences as both accounting manager ( 2007 ) and controller ( 2008 ) and finally as Vice President of Finance and Administration ( 2011 ).

PBIO Develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, they have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. The primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use PBIO products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.

NEEDS IN MEDICINE: In the world of medicine our dramatically improved ability for early detection or to confirm and refine diagnosis ranging from over a hundred types of cancer to tuberculosis and a hundred other maladies and conditions is “bottlenecked” by 30 year old methods of preparing test samples.  Collectively such diagnostic samples exceed a hundred million annually.

NEEDS IN RESEARCH: Globally there are over a half a million medical and pharmaceutical research scientists working in over eighty thousand laboratories who are hampered by the time consuming and outdated methods of preparing test samples.

NEEDS IN FORENSICS: Globally, in millions of cases, swift and sure exoneration of the innocent and / or justice for the guilty is often delayed or even denied because of the ponderous means of preparing and conducting DNA and other forensic testing.

PBIO is focused on solving the challenges of biological sample preparation, a crucial laboratory step performed globally by the biological life sciences research scientists. Sample preparation refers to a wide range of activities that precede most forms of scientific analysis. It is often complex, time-consuming and, in our opinion, one of the most error-prone steps of scientific research. Sample preparation is a ubiquitous laboratory undertaking – the requirements of which drive a large and growing worldwide market. PBIO has developed and patented a novel, enabling technology platform that can control the sample preparation process while improving both efficacy and quality.  It is based on harnessing the unique properties of high hydrostatic pressure. This process, called pressure cycling technology, or PCT, uses alternating cycles of hydrostatic pressure between ambient (normal atmosphere) and ultra-high levels i.e., 35,000 pounds per square inch (“psi”) or greater to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources.


The PBIO pressure cycling technology uses proprietary and internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures and specific time intervals, to rapidly and repeatedly control the interactions of bio-molecules, such as deoxyribonucleic acid (“DNA”), ribonucleic acid (“RNA”), proteins, lipids and small molecules. Their laboratory instrument, the Barocycler®, and their internally developed consumables product line, which include Pressure Used to Lyse Samples for Extraction (“PULSE”) tubes, and other processing tubes, and application specific kits such as consumable products and reagents, together make up their PCT Sample Preparation System (“PCT SPS”).


The PBIO pressure cycling technology takes a unique approach that has the potential for broad use in a number of established and emerging life sciences areas, which include:


  • Biological sample preparation in potentially thousands of research laboratories worldwide working in human, animal, plant, and microbial diseases and disorders – including but not limited to sample extraction, homogenization, and digestion in genomic, proteomic, lipidomic, metabolomic and small molecule study areas;
  • Pathogen inactivation (useful in vaccine development, infectious disease research, and more);
  • Protein purification, and in the control of chemical reactions, particularly enzymatic (useful in drug design and development);
  • and immunodiagnostics (useful in the development and detection of biomarkers).



PBIO has secured their technology through fourteen issued United States patents and ten issued foreign patents covering multiple applications of pressure cycling technology in the life sciences field.  They also have additional patents pending.  Research indicates that Pressure Bio Science, Inc. is the only company globally to have patents in this new science sector.




Night Food, Inc. (NGTF 0.17 )*  is a wholly-owned subsidiary of Night food Holdings incorporated in Nevada in 2013 to manufacture and distribute healthy-choice bedtime snacks. The Company has an exclusive agreement with RFI, natural ingredient manufacturer and proprietor of Chocamine, a patented chocolate ingredient

Americans keep gaining more weight. People have the tendency to grab for goodies at the end of the evening as they relax to enjoy some T.V. Eating and snacking too late at night is a contributing factor to gaining weight. Seventy percent of adults, ages 18-54, eat right before bed. Chocamine delivers the health benefits of chocolate to the body (amino acids, minerals and polyphenols) without the added sugars, caffeine or fat.

People give in to the intense hunger cravings that leads to the consumption of sugary, salty or calorie dense foods to satisfy their appetite. Most of the snacks that people typically eat create a disturbance in sleep, causing a person to wake up feeling unrested. Night Food offers nutrient filled alternatives to high-calorie junk foods. There are flavor filled snack bars-either Cookies and Dreams or Midnight Chocolate Crunch that will help curb hunger, satisfy cravings, improve rest and give the body essential vitamins and minerals.

Consumers spend over $50 billion/ year on night-time snacks, nearly 1 billion a week.  More people desire healthy alternatives to late night consumption of the traditional fattening ice cream, chips and cookies.

Sugar and caffeine in most snacks causes disruptive sleep. Each bar has only 142 calories and 5 grams of fiber for slow absorption of energy and gives a feeling of fullness and satisfaction. There is also 132 mg of calcium and zinc for replenishing the body and feeling well rested in the morning.


Leo Motors (LEOM: $ 0. 12 )* has patents for the electric battery industry which we will be writing about in upcoming weekly reports. They have developed a lithium battery that can operate vehicles in sub-zero climates. Their subsidiary LGM has developed battery technology supported by the Korean government to make it possible to use electric battery technology for fishing boats. They have a cartridge system which is a light-weight replacement method of swapping electric batteries.


Fishing has been harmed by the noise and oil leaks from internal combustion engines. LGM has solved that problem and besides eliminating the toxic problem, operating costs are reduced by 25%.


In addition they have a special patent for averting electric hazards and shocks. Leo developed the Internet of Things for e-boats which is networked and connected with an Android Operating System. Leo’s power supply system is CAN (Controller Area Network) based, which enables mobile diagnostics between mobile devices and boats using the Leo technology.


Leo is developing a battery swap system for Kalmado in Puerto Princesa, Philippines, a world famous   tourist attraction, which is focused on green energy. They will be converting 100 boats as the environment is expected to become 100% free of the toxicity from internal combustion engines. Also, Leo has developed a battery swap system for Go-Karts to be used in malls in China, Korea and Myanmar. Leo Motors has a new carbon nanotube battery power pack that functions and supplies full power in extreme low temperatures such as below 49 degrees without the need for grid electricity.



Skinvisible ( SKVI: $ 0.025 ) they have developed skin care products using its patented Invisicare polymer delivery systems and: transdermal cannabis products from hemp-derived CBD, with its new developments to include cannabinoids from marijuana CBD and THC.




Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:


Mike King

(702) 650-3000



Charles Moskowitz

 (781) 826-8882



Princeton Research

3887 Pacific Street,

Las Vegas, Nevada 89121


Where To Invest Now Newsletter


Where To Invest Now